£12m research centre will improve efficiency of rare disease trials to unlock tests and treatments
Researchers from BHP founder member the University of Birmingham are part of a new £12m research centre to improve clinical trials for rare diseases.
The LifeArc Centre for Acceleration of Rare …
Midlands-Wales Advanced Therapy Treatment Centre part of £17.9m network renewal
The Advanced Therapy Treatment Centre network includes the Midlands-Wales Advanced Therapy Treatment Centre, jointly delivered by BHP founding members the University of Birmingham and University Ho…
Launch of new international medical code for presymptomatic type 1 diabetes
Researchers at BHP founder-member the University of Birmingham have partnered with NHS England to produce a diagnostic code tailored for individuals in the early phases of type 1 diabetes, enhancin…
New Inflammatory Bowel Disease testing protocol could speed up diagnosis
Patients with suspected inflammatory bowel disease (IBD) could benefit from improved testing protocols that could reduce the need (and lengthy wait) for potentially unnecessary colonoscopies, a new…
Objective biomarker test could predict heart disease risk for patients with common arrhythmia
Patients with atrial fibrillation (AF) – a common heart arrhythmia – could have one blood test to assess their risk of cardiovascular events in the following five years, new research has found.
…
Understanding pregnancy: Accelerating the development of new therapies for pregnancy-specific conditions
During pregnancy, women and pregnant individuals who do not identify as women* can develop a range of pregnancy-specific conditions, such as preeclampsia and gestational diabetes, that can adversel…